[Ip-health] EXPERT MEETING: THE EU-CAN ASSOCIATION AGREEMENT - ACCESS TO MEDICINES IN JEOPARDY!

[Terri - Louise Beswick]

This is a multi-part message in MIME format.
--
[ Picked text/plain from multipart/alternative ]
In cooperation with the EU Coherence programme (www.eucoherence.org),
Health Action International, Europe is hosting an expert meeting on
Medicines, Access, Trade and Health, with a particular focus on the
bilateral negotiations on trade agreements between the European Union
and the four Andean community (CAN) countries: Bolivia, Colombia,
Ecuador, Peru.



Expert Meeting: The EU-CAN Association Agreement - access to medicines
in jeopardy!

Tuesday, February 17th, 2009

Morning- 10.00am - 12.30pm

European Parliament, Brussels



For more information, please see the Invitation
(http://www.haiweb.org/30012009/Invitation%20to%20EU-CAN%20Expert%20Meet
ing.pdf), Concept note
(http://www.haiweb.org/30012009/Concept%20note%20Expert%20EU-CAN%20IP%20
Meeting.pdf), and Preliminary Programme
http://www.haiweb.org/30012009/Preliminary%20Programme%20Expert%20EU-CAN
%20IP%20Meeting.pdf).



If you would like to attend, please contact Else Boonstra at EU
Coherence (eboonstra@evertvermeer.nl) or Terri Beswick at HAI
(terri@haiweb.org) before Friday, February 3rd, 2009.



This expert meeting is part of a broader campaign by Health Action
International, the Evert Vermeer Foundation and a coalition of civil
society organisations both in Europe and Latin America
(http://www.haiweb.org/02_focus_b.htm).



Kind regards,



Terri Beswick

Communications Officer



Health Action International

Overtoom 60/II

1054 HK Amsterdam

The Netherlands

Tel: +31 20 489 1077

Fax: +31 20685 5002

Email: terri@haiweb.org <mailto:tim@haiweb.org>

Website: http://www.haiweb.org <http://www.haiweb.org/>



Health Action International (HAI) is an independent, global network
working to increase access to essential medicines and improve their
rational use through research excellence and evidence-based advocacy.



Important Email Information:

The information contained in this email is confidential and may be
legally privileged.  It is intended solely for the addressee and is for
the exclusive use of the intended recipient(s). If you are not the
intended recipient(s), please note that any form of disclosure,
distribution, copying or use of this communication or the information in
it or in any attachments is strictly prohibited and may be unlawful. If
you are not the intended addressee, please contact the sender and
dispose of this e-mail immediately. Any opinions expressed are those of
the author, not of HAI.